The global Beta-lactam and Beta-lactamase Inhibitors market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Abbott Laboratories
Pfizer Inc.
GlaxoSmithKline plc
Allergan Plc.
Novartis International AG (Sandoz)
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd
Mylan N.V.
Merck & Co. Inc.
Sanofi
By Types:
Penicillin
Cephalosporin
Carbapenem
Monobactam
Combination
By Applications:
Oral
Intravenous
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Analysis from 2023 to 2028
1.5.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Beta-lactam and Beta-lactamase Inhibitors Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Beta-lactam and Beta-lactamase Inhibitors Industry Impact
Chapter 2 Global Beta-lactam and Beta-lactamase Inhibitors Competition by Types, Applications, and Top Regions and Countries
2.1 Global Beta-lactam and Beta-lactamase Inhibitors (Volume and Value) by Type
2.1.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption and Market Share by Type (2017-2022)
2.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Market Share by Type (2017-2022)
2.2 Global Beta-lactam and Beta-lactamase Inhibitors (Volume and Value) by Application
2.2.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption and Market Share by Application (2017-2022)
2.2.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Market Share by Application (2017-2022)
2.3 Global Beta-lactam and Beta-lactamase Inhibitors (Volume and Value) by Regions
2.3.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption by Regions (2017-2022)
4.2 North America Beta-lactam and Beta-lactamase Inhibitors Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Beta-lactam and Beta-lactamase Inhibitors Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Beta-lactam and Beta-lactamase Inhibitors Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Beta-lactam and Beta-lactamase Inhibitors Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Beta-lactam and Beta-lactamase Inhibitors Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Beta-lactam and Beta-lactamase Inhibitors Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Beta-lactam and Beta-lactamase Inhibitors Sales, Consumption, Export, Import (2017-2022)
4.10 South America Beta-lactam and Beta-lactamase Inhibitors Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Beta-lactam and Beta-lactamase Inhibitors Market Analysis
5.1 North America Beta-lactam and Beta-lactamase Inhibitors Consumption and Value Analysis
5.1.1 North America Beta-lactam and Beta-lactamase Inhibitors Market Under COVID-19
5.2 North America Beta-lactam and Beta-lactamase Inhibitors Consumption Volume by Types
5.3 North America Beta-lactam and Beta-lactamase Inhibitors Consumption Structure by Application
5.4 North America Beta-lactam and Beta-lactamase Inhibitors Consumption by Top Countries
5.4.1 United States Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
5.4.2 Canada Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
5.4.3 Mexico Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
Chapter 6 East Asia Beta-lactam and Beta-lactamase Inhibitors Market Analysis
6.1 East Asia Beta-lactam and Beta-lactamase Inhibitors Consumption and Value Analysis
6.1.1 East Asia Beta-lactam and Beta-lactamase Inhibitors Market Under COVID-19
6.2 East Asia Beta-lactam and Beta-lactamase Inhibitors Consumption Volume by Types
6.3 East Asia Beta-lactam and Beta-lactamase Inhibitors Consumption Structure by Application
6.4 East Asia Beta-lactam and Beta-lactamase Inhibitors Consumption by Top Countries
6.4.1 China Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
6.4.2 Japan Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
6.4.3 South Korea Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
Chapter 7 Europe Beta-lactam and Beta-lactamase Inhibitors Market Analysis
7.1 Europe Beta-lactam and Beta-lactamase Inhibitors Consumption and Value Analysis
7.1.1 Europe Beta-lactam and Beta-lactamase Inhibitors Market Under COVID-19
7.2 Europe Beta-lactam and Beta-lactamase Inhibitors Consumption Volume by Types
7.3 Europe Beta-lactam and Beta-lactamase Inhibitors Consumption Structure by Application
7.4 Europe Beta-lactam and Beta-lactamase Inhibitors Consumption by Top Countries
7.4.1 Germany Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
7.4.2 UK Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
7.4.3 France Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
7.4.4 Italy Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
7.4.5 Russia Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
7.4.6 Spain Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
7.4.7 Netherlands Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
7.4.8 Switzerland Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
7.4.9 Poland Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
Chapter 8 South Asia Beta-lactam and Beta-lactamase Inhibitors Market Analysis
8.1 South Asia Beta-lactam and Beta-lactamase Inhibitors Consumption and Value Analysis
8.1.1 South Asia Beta-lactam and Beta-lactamase Inhibitors Market Under COVID-19
8.2 South Asia Beta-lactam and Beta-lactamase Inhibitors Consumption Volume by Types
8.3 South Asia Beta-lactam and Beta-lactamase Inhibitors Consumption Structure by Application
8.4 South Asia Beta-lactam and Beta-lactamase Inhibitors Consumption by Top Countries
8.4.1 India Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
8.4.2 Pakistan Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Analysis
9.1 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Consumption and Value Analysis
9.1.1 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Under COVID-19
9.2 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Consumption Volume by Types
9.3 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Consumption Structure by Application
9.4 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Consumption by Top Countries
9.4.1 Indonesia Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
9.4.2 Thailand Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
9.4.3 Singapore Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
9.4.4 Malaysia Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
9.4.5 Philippines Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
9.4.6 Vietnam Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
9.4.7 Myanmar Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
Chapter 10 Middle East Beta-lactam and Beta-lactamase Inhibitors Market Analysis
10.1 Middle East Beta-lactam and Beta-lactamase Inhibitors Consumption and Value Analysis
10.1.1 Middle East Beta-lactam and Beta-lactamase Inhibitors Market Under COVID-19
10.2 Middle East Beta-lactam and Beta-lactamase Inhibitors Consumption Volume by Types
10.3 Middle East Beta-lactam and Beta-lactamase Inhibitors Consumption Structure by Application
10.4 Middle East Beta-lactam and Beta-lactamase Inhibitors Consumption by Top Countries
10.4.1 Turkey Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
10.4.3 Iran Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
10.4.5 Israel Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
10.4.6 Iraq Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
10.4.7 Qatar Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
10.4.8 Kuwait Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
10.4.9 Oman Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
Chapter 11 Africa Beta-lactam and Beta-lactamase Inhibitors Market Analysis
11.1 Africa Beta-lactam and Beta-lactamase Inhibitors Consumption and Value Analysis
11.1.1 Africa Beta-lactam and Beta-lactamase Inhibitors Market Under COVID-19
11.2 Africa Beta-lactam and Beta-lactamase Inhibitors Consumption Volume by Types
11.3 Africa Beta-lactam and Beta-lactamase Inhibitors Consumption Structure by Application
11.4 Africa Beta-lactam and Beta-lactamase Inhibitors Consumption by Top Countries
11.4.1 Nigeria Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
11.4.2 South Africa Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
11.4.3 Egypt Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
11.4.4 Algeria Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
11.4.5 Morocco Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
Chapter 12 Oceania Beta-lactam and Beta-lactamase Inhibitors Market Analysis
12.1 Oceania Beta-lactam and Beta-lactamase Inhibitors Consumption and Value Analysis
12.2 Oceania Beta-lactam and Beta-lactamase Inhibitors Consumption Volume by Types
12.3 Oceania Beta-lactam and Beta-lactamase Inhibitors Consumption Structure by Application
12.4 Oceania Beta-lactam and Beta-lactamase Inhibitors Consumption by Top Countries
12.4.1 Australia Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
12.4.2 New Zealand Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
Chapter 13 South America Beta-lactam and Beta-lactamase Inhibitors Market Analysis
13.1 South America Beta-lactam and Beta-lactamase Inhibitors Consumption and Value Analysis
13.1.1 South America Beta-lactam and Beta-lactamase Inhibitors Market Under COVID-19
13.2 South America Beta-lactam and Beta-lactamase Inhibitors Consumption Volume by Types
13.3 South America Beta-lactam and Beta-lactamase Inhibitors Consumption Structure by Application
13.4 South America Beta-lactam and Beta-lactamase Inhibitors Consumption Volume by Major Countries
13.4.1 Brazil Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
13.4.2 Argentina Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
13.4.3 Columbia Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
13.4.4 Chile Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
13.4.5 Venezuela Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
13.4.6 Peru Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
13.4.8 Ecuador Beta-lactam and Beta-lactamase Inhibitors Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Beta-lactam and Beta-lactamase Inhibitors Business
14.1 Abbott Laboratories
14.1.1 Abbott Laboratories Company Profile
14.1.2 Abbott Laboratories Beta-lactam and Beta-lactamase Inhibitors Product Specification
14.1.3 Abbott Laboratories Beta-lactam and Beta-lactamase Inhibitors Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Pfizer Inc.
14.2.1 Pfizer Inc. Company Profile
14.2.2 Pfizer Inc. Beta-lactam and Beta-lactamase Inhibitors Product Specification
14.2.3 Pfizer Inc. Beta-lactam and Beta-lactamase Inhibitors Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 GlaxoSmithKline plc
14.3.1 GlaxoSmithKline plc Company Profile
14.3.2 GlaxoSmithKline plc Beta-lactam and Beta-lactamase Inhibitors Product Specification
14.3.3 GlaxoSmithKline plc Beta-lactam and Beta-lactamase Inhibitors Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Allergan Plc.
14.4.1 Allergan Plc. Company Profile
14.4.2 Allergan Plc. Beta-lactam and Beta-lactamase Inhibitors Product Specification
14.4.3 Allergan Plc. Beta-lactam and Beta-lactamase Inhibitors Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Novartis International AG (Sandoz)
14.5.1 Novartis International AG (Sandoz) Company Profile
14.5.2 Novartis International AG (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Product Specification
14.5.3 Novartis International AG (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 F. Hoffmann-La Roche Ltd.
14.6.1 F. Hoffmann-La Roche Ltd. Company Profile
14.6.2 F. Hoffmann-La Roche Ltd. Beta-lactam and Beta-lactamase Inhibitors Product Specification
14.6.3 F. Hoffmann-La Roche Ltd. Beta-lactam and Beta-lactamase Inhibitors Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Teva Pharmaceutical Industries Ltd
14.7.1 Teva Pharmaceutical Industries Ltd Company Profile
14.7.2 Teva Pharmaceutical Industries Ltd Beta-lactam and Beta-lactamase Inhibitors Product Specification
14.7.3 Teva Pharmaceutical Industries Ltd Beta-lactam and Beta-lactamase Inhibitors Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Mylan N.V.
14.8.1 Mylan N.V. Company Profile
14.8.2 Mylan N.V. Beta-lactam and Beta-lactamase Inhibitors Product Specification
14.8.3 Mylan N.V. Beta-lactam and Beta-lactamase Inhibitors Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Merck & Co. Inc.
14.9.1 Merck & Co. Inc. Company Profile
14.9.2 Merck & Co. Inc. Beta-lactam and Beta-lactamase Inhibitors Product Specification
14.9.3 Merck & Co. Inc. Beta-lactam and Beta-lactamase Inhibitors Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Sanofi
14.10.1 Sanofi Company Profile
14.10.2 Sanofi Beta-lactam and Beta-lactamase Inhibitors Product Specification
14.10.3 Sanofi Beta-lactam and Beta-lactamase Inhibitors Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Beta-lactam and Beta-lactamase Inhibitors Market Forecast (2023-2028)
15.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Value and Growth Rate Forecast (2023-2028)
15.2 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Beta-lactam and Beta-lactamase Inhibitors Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Beta-lactam and Beta-lactamase Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Beta-lactam and Beta-lactamase Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Beta-lactam and Beta-lactamase Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Beta-lactam and Beta-lactamase Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Beta-lactam and Beta-lactamase Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Beta-lactam and Beta-lactamase Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Beta-lactam and Beta-lactamase Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Beta-lactam and Beta-lactamase Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast by Type (2023-2028)
15.3.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Type (2023-2028)
15.3.3 Global Beta-lactam and Beta-lactamase Inhibitors Price Forecast by Type (2023-2028)
15.4 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Volume Forecast by Application (2023-2028)
15.5 Beta-lactam and Beta-lactamase Inhibitors Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 129 |
| Price : US$ 2450 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 269 |
| Price : US$ 2450 |
Date : Feb 2024 |
| Category : Electronics |
Pages : 261 |
Request Sample 
Request Discount 
Inquire Before Buy
